IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v34y2016i2d10.1007_s40273-015-0378-4.html
   My bibliography  Save this article

Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis

Author

Listed:
  • Eberechukwu Onukwugha

    (University of Maryland School of Pharmacy)

Abstract

No abstract is available for this item.

Suggested Citation

  • Eberechukwu Onukwugha, 2016. "Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis," PharmacoEconomics, Springer, vol. 34(2), pages 91-93, February.
    • Handle: RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0378-4
    DOI: 10.1007/s40273-015-0378-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-015-0378-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-015-0378-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Chris Schilling & Duncan Mortimer & Kim Dalziel & Emma Heeley & John Chalmers & Philip Clarke, 2016. "Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease," PharmacoEconomics, Springer, vol. 34(2), pages 195-205, February.
    2. Paula K. Lorgelly & Brett Doble & Rachel J. Knott, 2016. "Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015," PharmacoEconomics, Springer, vol. 34(2), pages 139-154, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sarah Neubauer & Kristine Kreis & Mike Klora & Jan Zeidler, 2017. "Access, use, and challenges of claims data analyses in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(5), pages 533-536, June.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Eberechukwu Onukwugha, 2016. "Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis," PharmacoEconomics, Springer, vol. 34(2), pages 91-93, February.
    2. Mona Aghdaee & Bonny Parkinson & Kompal Sinha & Yuanyuan Gu & Rajan Sharma & Emma Olin & Henry Cutler, 2022. "An examination of machine learning to map non‐preference based patient reported outcome measures to health state utility values," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1525-1557, August.
    3. Banzragch Nandintsetseg & Masato Shinoda & Baasandai Erdenetsetseg, 2018. "Contributions of multiple climate hazards and overgrazing to the 2009/2010 winter disaster in Mongolia," Natural Hazards: Journal of the International Society for the Prevention and Mitigation of Natural Hazards, Springer;International Society for the Prevention and Mitigation of Natural Hazards, vol. 92(1), pages 109-126, November.
    4. Schilling, Chris & Knight, Josh & Mortimer, Duncan & Petrie, Dennis & Clarke, Philip & Chalmers, John & Kerr, Andrew & Jackson, Rod, 2017. "Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk," Health Policy, Elsevier, vol. 121(12), pages 1233-1239.
    5. Daisuke Goto & Ya-Chen Tina Shih & Pascal Lecomte & Melvin Olson & Chukwukadibia Udeze & Yujin Park & C. Daniel Mullins, 2017. "Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(7), pages 685-695, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0378-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.